Oklahoma does not plan to reveal whether it has abided by the request of a drug maker to return a sedative it uses in its executions that is also at the center of a case before the U.S. Supreme Court, officials said on Friday. Akorn Inc sent a letter to the Oklahoma Attorney General in March saying the use of its drug midazolam for executions violated U.S. drug protocols and asked the state to return what it had purchased.